Latest news
Loading news…
KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.
KaNDy Therapeutics was acquired by Bayer in 2020 for $450M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Stevenage, Herefordshire, United Kingdom
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to KaNDy Therapeutics
Loading news…
FAQs about KaNDy Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.